Mainstream

Pulse Biosciences outlines initial percutaneous electrode revenue and IDE milestones while expanding nsPFA clinical programs

Pulse Biosciences outlines initial percutaneous electrode revenue and IDE milestones while expanding nsPFA clinical programs

Post ContentplseRead More

You might also be interested in reading Goldman Foresees Q2 2024 Fed Rate Cut: A Boost For Bitcoin?.

August 13, 2025
In Mainstream